Skip to main content

NPPA has fixed/revised ceiling prices/retail prices of 37 formulations under DPCO , 2013

 

Clinical courses

 

Clinical courses

NPPA has fixed/revised ceiling prices/retail prices of 37 formulations under DPCO , 2013. The different formulation are:

Rosuvastatin + Aspirin+ Clopidogrel Capsule (R2 Trio 10), Rosuvastatin + Aspirin + Clopidogrel Capsule (R2 Trio 20), Atorvastatin + Clopidogrel Capsule (Stator CV), Amoxycillin + Clavulnic Suspension, Paclitaxel Injection (Nab-Altaxel 100mg), Escitalopram + Clonazepam Tablet (Szetalo Plus 5), Teneligliptin + Metformin Tablet (Terostil M), Glimepride + Metformin Tablet (Glimison-M2 Forte), Glimepride + Metformin Tablet (Glimison-M1 Forte), Metoprolol + Amlodipine Tablet (MPROL-AM 25/5), Telmisartan + Chlorthalidone Tablet (Telmiride – CH 6.25), Telmisartan + Chlorthalidone Tablet, Ferrous + Folic Acid + Elemental Tablet (Tonofolic – XT), Voglibose + Glimepride + Metformin Tablet (Voglyson GM1), Voglibose + Glimepride + Metformin Tablet (Voglyson GM2), Doxorubicin Injection, Glimiepiride + Metformin Tablet (GLYCOMET GP 3 Forte), Rosuvastation + Aspirin + Clopidogrel capsule, Rosuvastation + Aspirin + Clopidogrel Capsule, Paclitaxel (Protein bound Particles) for Injectable Suspension, Glimepiride + Metformin Tablet (Glimy M 0.5mg), Gliclazide + Metformin Tablet, Doxorubicin Hydrochloride liposomal Injection, Teneligliptin + Metformin Tablet, Rosuvastatin + Aspirin Capsules, Metformin + Glimepiride Tablet, Amoxycillin + Clavulanic Dry Syrup

Other formulations are: Diclofenac + Methyl Salcylate + Menthol (Volini Maxx Spray in 15gm Pack), Diclofenac + Methyl Salcylate + Menthol (Volini Maxx Spray in 15,30, 40, 60 gm Pack), Atorvastatin + Aspirin + Clopidogrel capsule, Phenytoin Oral Liquid, BCG Vaccine, Ferrous Salt(A) + Folic acid (B) - (100mg + 500mcg) Tablet

The manufacturer shall issue a price list in Form–V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and dealers.

Every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same.

<< Back to Pharma News

Subscribe to PharmaTutor News Alerts by Email